Seminar Detail

Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

Where:  LANCASTER, PA

When:  Tuesday, August 15, 2017 at 8:00 AM - 4:00 PM

This event is no longer available for purchase.

Other ways to Register: Call (800) 844-8260  
Details

$219.99
Single Registration
$199.99
2+ Group Rate: per person
*** All prices are shown in US Dollars ***
 
View brochure for CE details
Location

DOUBLETREE RESORT LANCASTER/WILLOW VALLEY
2400 WILLOW STREET PIKE
LANCASTER,PA 17602
Phone: 717-464-2711
View Map

Alternate Locations

Student Discounts
If you are a student, please click here for registration information.

Group Discounts
If 5+ staff members from your facility are attending this event, please call (800) 844-8260 to learn more about our special rates.

In-House Options
If you would like this educational event brought to your facility, please click here for in-house training options.

Course Description
Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.
If there is no CE tab, please refer to the course brochure for continuing education information.
Learner Objectives:

  1. Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
  2. Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
  3. Distinguish between different types of bacterial etiology and mechanisms of resistance.
  4. Compare empiric dosing of antimicrobials.
  5. Recognize important interactions between antimicrobials and other drugs.
  6. Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
  7. Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
  8. Develop preventative strategies to limit antimicrobial resistance.
  9. Design patient and caregiver education on the proper use of antimicrobials.
  10. Differentiate local and global ecological factors affecting promotion of viral infection emergence.
  11. Plan for vaccines that are currently recommended for routine administration.
Program Outline

  • Antimicrobials
    • Drug classes
    • Pharmacokinetic Properties
      • Concentration-dependent killing
      • Time-dependent killing
      • Post-antibiotic effect
    • Common interactions with other drugs
  • Antibacterial Allergies - Sulfa and Penicillin
    • Define true allergy
    • Sulfonamide antibiotics vs non-antibiotics
    • Penicillin - Cephalosporin cross-sensitivity
  • Bacteria
    • Differentiation
    • Normal flora
    • Common pathogens
  • Antibacterial Resistance - Contributing Factors
    • Trends
    • Mechanisms of resistance
    • Contributing factors
  • Methicillin-Resistant Staphylococcus Aureus - Community versus Hospital Acquired
    • Differentiating between CA- and HA-MRSA
    • Current clinical practice guidelines
    • Pharmacologic management
  • Enterobacteriaceae Resistance
    • Extended Spectrum Beta-Lactamase (ESBL)
      • What are ESBLs
      • Pharmacologic management
    • Carbapenem-Resistant Enterobacteriaceae (CRE)
      • What are CREs
      • Pharmacologic management
  • Urinary Tract Infections
    • Bacterial Etiology, Signs and Symptoms and Diagnosis
    • Cystitis and pyelonephritis
    • Complicated and uncomplicated
    • UTIs in pregnancy
    • Treatment (IDSA Guideline Treatment Algorithm)
      • Acute
      • Recurrent and relapse
  • Clostridium Difficile Infection
    • Risk factors
    • Pharmacology management
    • Fecal Transplantation
    • Probiotics literature review
  • Community–Acquired Pneumonia
    • Bacterial etiology
    • Diagnosis
    • Typical vs. atypical
    • Treatment (IDSA/ATS Guidelines) and monitoring
      • Outpatient vs. inpatient
      • Empiric treatment
  • Healthcare–Associated Pneumonia
    • Bacterial etiology
    • Treatment (IDSA/ATS Guidelines)
    • Treatment Controversy
  • Upper Respiratory Tract Infections
    • Sinusitis and pharyngitis
      • Etiology (Viral vs. Bacterial)
      • Treatment
    • Bronchitis and Pertussis
      • Etiology (Viral vs. Bacterial)
      • Treatment
  • Skin and Soft Tissue Infections
    • Cellulitis
    • Diabetic foot infections
    • Bacterial etiology
      • Signs & symptoms
      • Treatment (IDSA Guidelines)
    • Osteomyelitis
      • Acute vs. Chronic
      • Oral considerations
  • Strategies to Improve Patient Adherence
    • IMS Model (Information-Motivation-Strategy)
    • Major predictors of poor adherence to medication
  • Antibacterial Resistance – Prevention Strategies
    • Mechanisms for drug resistance
    • 12 steps to prevent antimicrobial resistance (CDC)
    • Antibiotic stewardship
  • Emerging and Reemerging Viral Infections
    • Animals as sources
    • Drivers and ecological factors
    • Modes of transmission
    • Pharmacology management
  • Influenza
    • Clinical features
    • Diagnosis
    • Pharmacology management
  • Immunizations (Adult)
    • Types of Vaccines
    • General recommendations
    • Contraindications & precautions

ERIC WOMBWELL, PHARMD, BCPS

Eric Wombwell is a Board Certified Pharmacotherapy Specialist and Clinical Assistant Professor for the Department of Pharmacy Practice and Administration at the University of Missouri - Kansas City, School of Pharmacy. Dr. Wombwell completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center.

Dr. Wombwell coordinates the pharmacy school courses of Pharmacotherapy II and Zoonotic Illnesses, and provides didactic lectures on infectious disease, hematology/oncology, and zoonoses topics for UMKC, where he has received multiple teaching recognitions. He is frequently invited to speak locally and nationally to nurse and pharmacist groups on a variety of infectious disease topics. Dr. Wombwell is published often in the areas of teaching, immunizations, and pharmacologic management of infectious diseases. In addition to his teaching, speaking, and research responsibilities, Dr. Wombwell practices as a clinical pharmacy specialist at Centerpoint Medical Center in Independence, Missouri emphasizing antimicrobial stewardship and pharmacokinetic dosing of antimicrobials. His professional interests include emerging and reemerging infectious pathogens and educational technology.



Speaker Disclosures:

Financial: Eric Wombwell is a Clinical Assistant Professor, Department of Pharmacy Practice at the University of Missouri – Kansas City. He receives a speaking honorarium from PESI, Inc.

Non-financial: Eric Wombwell has no relevant nonfinancial relationships to disclose.
MIDWIVES
This course has been reviewed and approved for ACNM specialty credit. Full attendance at this course qualifies for .625 CEUs. ACNM Program #: 2016/059.


NURSES/NURSE PRACTITIONER/CLINICAL NURSE SPECIALISTS
American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 6.3 contact hours. PARTIAL CONTACT HOURS WILL BE AWARDED FOR PARTIAL ATTENDANCE.


NURSE PRACTITIONERS
This program offers 380 instructional minutes of pharmacology content which is designed to qualify for 6.3 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.


PHARMACISTS
ACPE Logo
PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 6.3 contact hours. ACPE Universal Program Number: 0289-0000-17-040-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. You are required to complete a program evaluation/post-test and bring your e-Profile ID to the seminar to receive CPE credit. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.


PHYSICIAN ASSISTANTS
AAPA Logo
This program has been reviewed and is approved for a maximum of 6.25 hours of clinical Category I CME credit by the American Academy of Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Live Programs and for Commercial Support of Live Programs.


OTHER PROFESSIONS
This activity qualifies for 380 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates